Synergistic effect of the angiogenesis inhibitor TNP-470 and tumor necrosis factor (TNF) on Bomirski Ab melanoma in hamsters.
Bomirski Ab transplantable melanoma bearing hamsters were treated with angiogenesis inhibitor TNP-470 or with rat tumor necrosis factor (TNF) at doses of 20 micrograms and 40 micrograms or with both TNP-470 and TNF at a dose of 20 micrograms each. The size of the growing tumor was measured everyday from the day when it was palpable. After the death of the animals the final size of their tumors was measured and the number and localisation of metastasis were determined. It was found that the rate of tumor growth was lowest in the group of animals treated with TNF at a dose of 40 micrograms and in the group of animals treated with TNP-470 and TNF at a dose of 20 micrograms. The frequency of metastasis was different in the experimental groups although their location was similar. The longest living animals belonged to the group treated with both TNP-470 and TNF. The results of the investigation indicate that TNP-470 and TNF act in a synergistic way that allows a decrease in the effective dose of TNF thus diminishing its noxious side effects.
Myśliwski
A
A
Department of Histology and Immunology, Medical University of Gdánsk, 80-210 Gdánsk, Poland. amnys@amedec.amg.gda.pl
Bigda
J
J
Koszałka
P
P
Szmit
E
E
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D006224:Cricetinae; D003510:Cyclohexanes; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D008297:Male; D008546:Melanoma, Experimental / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D008647:Mesocricetus; D000077609:O-(Chloroacetylcarbamoyl)fumagillol; D012717:Sesquiterpenes / Q000494:pharmacology*; D016019:Survival Analysis; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D020533:Angiogenesis Inhibitors; D003510:Cyclohexanes; D012717:Sesquiterpenes; D014409:Tumor Necrosis Factor-alpha; D000077609:O-(Chloroacetylcarbamoyl)fumagillol